Back to top

cancer: Archive

Rajshree Sipani

UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?

UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.

UNHPositive Net Change CNCNegative Net Change

Debanjana Dey

BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

bioAffinity and Biodesix pursue different cancer diagnostics strategies, but which oncology stock offers better long-term upside? Let's dive in.

BDSXNegative Net Change BIAFNegative Net Change

Debanjana Dey

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which life sciences stock offers better long-term upside? Let's dive in.

CSBRNegative Net Change CTKBNegative Net Change

Mark Zinski

2 Microcaps With Gross Margin Catalysts

CSBR and CEPL have levers in place for Gross Margin improvement.

CSBRNegative Net Change CEPLNegative Net Change

Debanjana Dey

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?

Aspira and Myriad Genetics take different approaches to women's health diagnostics, but which stock looks more compelling now? Let's dive in.

MYGNNegative Net Change AWHLNegative Net Change

Debanjana Dey

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.

NEONegative Net Change PRPONegative Net Change

Kinjel Shah

3 Cancer Stocks to Watch as Oncology Innovation Accelerates

Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeline growth and spotlight promising cancer-focused stocks.

AUTLNegative Net Change NXTCNegative Net Change RXRXNegative Net Change AZNNegative Net Change NVSNegative Net Change JNJPositive Net Change PFENegative Net Change

Ekta Bagri

4 Biotech Stocks Investors Should Watch in 2026

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position LQDA, IMNM, STOK and IMCR well in this volatile sector.

LQDANegative Net Change STOKNegative Net Change IMNMNegative Net Change IMCRNegative Net Change

Kinjel Shah

Cancer Stocks That Are Advancing the Future of Oncology Care

Oncology innovation is accelerating as AI, immunotherapy and targeted drugs drive growth for cancer-focused biotech and pharma stocks.

AZNNegative Net Change NVSNegative Net Change JNJPositive Net Change PFENegative Net Change VSTMNegative Net Change SMMTNegative Net Change XLOPositive Net Change

Kinjel Shah

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Oncology is evolving fast as immunotherapy, AI and targeted drugs expand treatment options, boost outcomes, and fuel long-term healthcare growth.

AZNNegative Net Change NVSNegative Net Change JNJPositive Net Change PFENegative Net Change MRKPositive Net Change VSTMNegative Net Change XLOPositive Net Change